Primo Biotech Lazio is a venture capital fund investing in biotechnologies, with a focus on turning scientific excellence into scalable companies. Rooted in Lazio’s strong research, clinical and pharmaceutical ecosystem, the fund aims to support companies from scientific validation through clinical, regulatory and commercial development. The fund was established with the support of Lazio Innova, as part of the LAZIO Venture 2 programme, the fund of funds of the Lazio Region, co-financed by the 2021–2027 ERDF Regional Programme. The fund will invest in biotech startups with initial ticket up to €6 million euros.